13F HOLDINGS REPORT
Sands Capital Ventures, LLC
Quarter ended Q1 2023 · Filed February 13, 2023 · Accession 0001846444-23-000001
Total Value
$365,127
Positions
24
Other Managers
0
Confidential Omitted
No
Holdings (24)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DICE THERAPEUTICS, INC. | 23345J104 | 2,748,970 | $85,768 | 23.49% |
| 2 | UIPATH INC | PATH | 3,816,569 | $48,509 | 13.29% |
| 3 | NU HOLDINGS LTD. | NU | 9,156,347 | $37,266 | 10.21% |
| 4 | SAMSARA, INC. | IOT | 2,712,256 | $33,713 | 9.23% |
| 5 | SNOWFLAKE INC | SNOW | 215,535 | $30,938 | 8.47% |
| 6 | DOORDASH INC | DASH | 603,512 | $29,463 | 8.07% |
| 7 | ACRIVON THERAPEUTICS, INC. | ACRV | 1,652,605 | $19,038 | 5.21% |
| 8 | ACUMEN PHARMACEUTICALS, INC | ABOS | 3,417,075 | $18,452 | 5.05% |
| 9 | OLINK HOLDING AB | OLN | 705,514 | $17,906 | 4.90% |
| 10 | 10X Genomics, Inc. | TXG | 481,770 | $17,556 | 4.81% |
| 11 | KARUNA THERAPEUTICS, INC. | 48576A100 | 58,895 | $11,573 | 3.17% |
| 12 | SAMSARA, INC. | IOT | 332,520 | $4,133 | 1.13% |
| 13 | TARSUS PHARMACEUTICALS INC | TARS | 260,000 | $3,812 | 1.04% |
| 14 | 908 DEVICES INC | MASS | 326,427 | $2,487 | 0.68% |
| 15 | TAYSHA GENE THERAPIES INC | TSHA | 724,873 | $1,638 | 0.45% |
| 16 | CANDEL THERAPEUTICS, INC | CADL | 811,737 | $1,453 | 0.40% |
| 17 | SPRUCE BIOSCIENCES INC | SPRB | 787,007 | $866 | 0.24% |
| 18 | ABSCI CORP. | ABSI | 57,804 | $121 | 0.03% |
| 19 | COUPANG INC | CPNG | 6,971 | $103 | 0.03% |
| 20 | DATADOG INC | DDOG | 1,366 | $100 | 0.03% |
| 21 | CROWDSTRIKE HOLDINGS INC | CRWD | 864 | $91 | 0.02% |
| 22 | TOAST INC | TOST | 4,494 | $81 | 0.02% |
| 23 | CONFLUENT INC CLASS A - ADR | 20717M103 | 1,354 | $30 | 0.01% |
| 24 | GITLAB INC. | GTLB | 658 | $30 | 0.01% |